Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024Journal of the National Comprehensive Cancer NetworkOpen Access

Non–Small Cell Lung Cancer, Version 4.2024

View Full Paper
Ask AI
Bookmark
Share

Authors

Gregory J. RielyGregory J. RielyNorthside HospitalDWDouglas E. WoodDartmouth–Hitchcock Medical CenterDEDavid S. EttingerJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Riely et al. (2024) studied this question.

synapsesocial.com/papers/68e6c02bb6db64358763f43fhttps://doi.org/10.6004/jnccn.2204.0023
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer2015 · 9,577 citations
  2. 2Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study2021 · 659 citations
  3. 3Sotorasib for Lung Cancers with KRAS p.G12C Mutation2021 · 1,884 citations